SGLT-2 inhibitors promote more efficient energy use, enhancing myocardial metabolic flexibility, improving the heart’s ability to adapt to stress, and reducing the incidence of heart failure (Figure 3). The gene discussed is SLC5A2; the disease is heart failure.